Sample entropy and surrogate data analysis for Alzheimer's disease

Area of Science:

• Neuroscience
• Biomedical Engineering
• Signal Processing

Background:

• Alzheimer's disease (AD) is a progressive neurological disorder characterized by memory loss.
• Electroencephalogram (EEG) is a cost-effective, portable, and non-invasive tool for studying brain activity in AD.
• Quantifying brain signal complexity is crucial for understanding neurological changes in AD.

Purpose of the Study:

• To develop and validate a method for distinguishing Alzheimer's disease patients from healthy subjects using EEG.
• To investigate the impact of Alzheimer's disease on the complexity of brain activity as measured by EEG.
• To assess the utility of sample entropy (SampEn) combined with surrogate data analysis for AD detection.

Main Methods:

• Analysis of EEG data from 14 Alzheimer's disease patients and 20 healthy subjects.
• Application of classical sample entropy (SampEn) to quantify signal complexity.
• Generation and comparison of surrogate data to validate findings from original EEG time series.
• Statistical analysis to determine significant differences in SampEn between groups and data types.

Main Results:

• Significantly decreased SampEn was observed in AD patients compared to healthy subjects at electrodes c3, f3, o2, and p4, indicating loss of complexity.
• Significant differences in SampEn between original EEG data and surrogate data were found at electrodes c3 and o2.
• The combined method successfully verified differences between healthy subjects and AD patients, consistent with physiological complexity changes.

Conclusions:

• The proposed method, combining SampEn and surrogate data analysis, effectively distinguishes Alzheimer's disease patients from healthy individuals.
• Reduced physiological complexity in EEG signals is a quantifiable marker associated with Alzheimer's disease.
• This approach offers valuable insights into the neurophysiological underpinnings of AD and aids in diagnostic strategies.